158 related articles for article (PubMed ID: 3766490)
1. Aztreonam therapy for serious gram-negative infections in children.
Stutman HR; Chartrand SA; Tolentino T; Friedhoff L; Marks MI
Am J Dis Child; 1986 Nov; 140(11):1147-51. PubMed ID: 3766490
[TBL] [Abstract][Full Text] [Related]
2. Clinical experience with aztreonam for treatment of infections in children.
Stutman HR
Rev Infect Dis; 1991; 13 Suppl 7():S582-5. PubMed ID: 2068462
[TBL] [Abstract][Full Text] [Related]
3. Summary of worldwide clinical trials of aztreonam in patients with urinary tract infections.
Swabb EA; Jenkins SA; Muir JG
Rev Infect Dis; 1985; 7 Suppl 4():S772-7. PubMed ID: 3909336
[TBL] [Abstract][Full Text] [Related]
4. Aztreonam in the treatment of aerobic, gram-negative bacillary infections in pediatric patients.
Trujillo H; Harry N; Arango A; Benítez G; Restrepo F; Mejía GI; Castrillón AL
Chemotherapy; 1989; 35 Suppl 1():25-30. PubMed ID: 2731447
[TBL] [Abstract][Full Text] [Related]
5. Successful response of severe neonatal gram-negative infection to treatment with aztreonam.
Constantopoulos A; Thomaidou L; Loupa H; Papoulias G
Chemotherapy; 1989; 35 Suppl 1():101-5. PubMed ID: 2731446
[TBL] [Abstract][Full Text] [Related]
6. Aztreonam in the treatment of gram-negative bacterial meningitis.
Lentnek AL; Williams RR
Rev Infect Dis; 1991; 13 Suppl 7():S586-90. PubMed ID: 2068463
[TBL] [Abstract][Full Text] [Related]
7. Aztreonam in the treatment of gram-negative meningitis and other gram-negative infections.
Feris J; Moledina N; Rodriguez WJ; Khan WN; Puig J; Wiedermann BL; Ahmad S
Chemotherapy; 1989; 35 Suppl 1():31-8. PubMed ID: 2731448
[TBL] [Abstract][Full Text] [Related]
8. Use of aztreonam in the treatment of serious infections due to multiresistant gram-negative organisms, including Pseudomonas aeruginosa.
Scully BE; Neu HC
Am J Med; 1985 Feb; 78(2):251-61. PubMed ID: 4038574
[TBL] [Abstract][Full Text] [Related]
9. Aztreonam: the first monobactam.
Neu HC
Med Clin North Am; 1988 May; 72(3):555-66. PubMed ID: 3280906
[TBL] [Abstract][Full Text] [Related]
10. Aztreonam therapy for serious gram-negative bacillary infections.
Cone LA; Woodard DR
Rev Infect Dis; 1985; 7 Suppl 4():S794-802. PubMed ID: 3909339
[TBL] [Abstract][Full Text] [Related]
11. Clinical experience with aztreonam in four Mediterranean countries.
Daikos GK
Rev Infect Dis; 1985; 7 Suppl 4():S831-5. PubMed ID: 2934787
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of aztreonam therapy for serious infections due to gram-negative bacteria.
McKellar PP
Rev Infect Dis; 1985; 7 Suppl 4():S803-9. PubMed ID: 3909340
[TBL] [Abstract][Full Text] [Related]
13. Aztreonam in the treatment of severe urinary tract infections in pediatric patients.
Rusconi F; Assael BM; Boccazzi A; Colombo R; Crossignani RM; Garlaschi L; Rancilio L
Antimicrob Agents Chemother; 1986 Aug; 30(2):310-4. PubMed ID: 3094442
[TBL] [Abstract][Full Text] [Related]
14. Aztreonam in the treatment of serious gram-negative infections in the elderly.
Deger F; Douchamps J; Freschi E; Thys JP; Nève P; Herchuelz A
Int J Clin Pharmacol Ther Toxicol; 1988 Jan; 26(1):22-6. PubMed ID: 3403089
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of aztreonam in the treatment of serious gram-negative infections in a university hospital in Saudi Arabia.
Fayed DF; Dahmash NS; Saddique AA; Shibl AM
J Chemother; 1992 Jun; 4(3):167-70. PubMed ID: 1517810
[TBL] [Abstract][Full Text] [Related]
16. Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Brogden RN; Heel RC
Drugs; 1986 Feb; 31(2):96-130. PubMed ID: 3512234
[TBL] [Abstract][Full Text] [Related]
17. Comparison of empiric aztreonam and aminoglycoside regimens in the treatment of serious gram-negative lower respiratory infections.
Bjornson HS; Ramirez-Ronda C; Saavedra S; Rivera-Vázquez CR; Liu C; Hinthorn DR
Clin Ther; 1993; 15(1):65-78. PubMed ID: 8458056
[TBL] [Abstract][Full Text] [Related]
18. Aztreonam in gram-negative infections in children.
Sklavunu-Tsurutsoglu S; Gatzola-Karaveli M; Hitoglu-Makedu A; Paradelis AG; Tsurutsoglu G
Chemioterapia; 1987 Jun; 6(2 Suppl):415-7. PubMed ID: 3509461
[No Abstract] [Full Text] [Related]
19. Efficacy and safety of aztreonam in the treatment of patients with renal failure.
Sion ML; Pyrpasopoulos M; Nicolaidis P; Papagianni C; Tsurutsoglu G
Rev Infect Dis; 1991; 13 Suppl 7():S652-4. PubMed ID: 2068477
[TBL] [Abstract][Full Text] [Related]
20. Clinical experience with aztreonam in Europe: a summary of studies in Belgium, England, Finland, Ireland, the Netherlands, Norway, Portugal, and Sweden.
Norrby SR
Rev Infect Dis; 1985; 7 Suppl 4():S836-9. PubMed ID: 2934788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]